Literature DB >> 27709412

Acromegalic osteopathy.

G Mazziotti1,2, F Maffezzoni1, S Frara1, A Giustina3.   

Abstract

Acromegalic osteopathy is an emerging complication of acromegaly characterized by increase in bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures. Vertebral fractures, as diagnosed by a radiological and morphometric approach, occur in about one-third of acromegaly patients in close relationship with duration of active disease. However, the prediction of vertebral fractures in this clinical setting is still a matter of uncertainty, since the pathogenesis of acromegalic osteopathy is multifactorial and fractures may occur even in presence of normal bone mineral density. In this narrative article, we summarize the pathophysiology and clinical aspects of acromegalic osteopathy.

Entities:  

Keywords:  Acromegaly; Fractures; Growth hormone; IGF-I; Osteoporosis

Mesh:

Substances:

Year:  2017        PMID: 27709412     DOI: 10.1007/s11102-016-0758-6

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  70 in total

1.  Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.

Authors:  M J Kayath; J G Vieira
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 2.  New advances in imaging osteoporosis and its complications.

Authors:  James F Griffith; Harry K Genant
Journal:  Endocrine       Date:  2012-05-23       Impact factor: 3.633

3.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

4.  The nature of the metabolic bone disorder in acromegaly.

Authors:  B L Riggs; R V Randall; H W Wahner; J Jowsey; P J Kelly; M Singh
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

Review 5.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

Review 6.  The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly.

Authors:  Adnan Ajmal; Arezoo Haghshenas; Shirin Attarian; Maya Barake; Nicholas A Tritos; Anne Klibanski; Karen K Miller; Lisa B Nachtigall
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 7.  Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.

Authors:  Patrick Maison; Anne-Isabelle Tropeano; Isabelle Macquin-Mavier; Andrea Giustina; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2007-02-20       Impact factor: 5.958

Review 8.  Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

Authors:  Peter Kamenický; Gherardo Mazziotti; Marc Lombès; Andrea Giustina; Philippe Chanson
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

9.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

Review 10.  Skeletal Fragility in Endogenous Hypercortisolism.

Authors:  Gherardo Mazziotti; Adriano Delgado; Filippo Maffezzoni; Annamaria Formenti; Andrea Giustina
Journal:  Front Horm Res       Date:  2016-05-17       Impact factor: 2.606

View more
  12 in total

1.  Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.

Authors:  S Chiloiro; M Mormando; A Bianchi; A Giampietro; D Milardi; C Bima; G Grande; A M Formenti; G Mazziotti; A Pontecorvi; A Giustina; L De Marinis
Journal:  Endocrine       Date:  2017-08-23       Impact factor: 3.633

2.  Frequency of hyperostosis frontalis interna in patients with active acromegaly: is there a possible role of GH excess or hyperprolactinemia in its etiopathogenesis?

Authors:  Ummu Mutlu; Ozge Telci Caklili; Mehmet Barburoglu; Sema Yarman
Journal:  Hormones (Athens)       Date:  2022-10-12       Impact factor: 3.419

3.  Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Authors:  L Dalle Carbonare; V Micheletti; E Cosaro; M T Valenti; M Mottes; G Francia; M V Davì
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

4.  Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Authors:  Sabrina Chiloiro; Gherardo Mazziotti; Antonella Giampietro; Antonio Bianchi; Stefano Frara; Marilda Mormando; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 5.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

6.  Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study.

Authors:  Madalina Cristina Sorohan; Roxana Dusceac; Bogdan Marian Sorohan; Andra Caragheorgheopol; Catalina Poiana
Journal:  Arch Osteoporos       Date:  2021-09-16       Impact factor: 2.617

7.  Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.

Authors:  Tiffany L Wormhoudt; Mary-Keara Boss; Katharine Lunn; Lynn Griffin; Del Leary; Kristy Dowers; Sangeeta Rao; Susan M LaRue
Journal:  J Vet Intern Med       Date:  2018-05-21       Impact factor: 3.333

8.  3D DXA Hip Differences in Patients with Acromegaly or Adult Growth Hormone Deficiency.

Authors:  Luis Gracia-Marco; Sheila Gonzalez-Salvatierra; Antonia Garcia-Martin; Esther Ubago-Guisado; Beatriz Garcia-Fontana; José Juan Gil-Cosano; Manuel Muñoz-Torres
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 9.  Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting.

Authors:  Maria Fleseriu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

10.  Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study.

Authors:  E Sala; E Malchiodi; G Carosi; E Verrua; E Cairoli; E Ferrante; M Filopanti; C Eller-Vainicher; F M Ulivieri; A Spada; M Arosio; I Chiodini; G Mantovani
Journal:  J Endocr Soc       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.